Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia

Max J. Gordon, Phil Raess, Kathleen Young, Stephen Spurgeon, Alexey Danilov

Research output: Contribution to journalArticle

8 Scopus citations
Original languageEnglish (US)
JournalBritish Journal of Haematology
DOIs
StateAccepted/In press - 2016

Keywords

  • Cytogenetics
  • Ibrutinib
  • Prolymphocytic leukaemia

ASJC Scopus subject areas

  • Hematology

Cite this